WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

计划入组 310 人 · 首次发布于 2012 年 8 月 7 日

Evaluation of High Dose Rifampicin and Dialkylcarbamoyl chloride (DACC)-coated dressings to improve outcomes in Mycobacterium ulcerans disease

计划入组 112 人

BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA

计划入组 151 人 · 首次发布于 2006 年 5 月 3 日

Mycobacterium ulcerans vaccine (Swiss TPH Institute/Telormedix)

Mycobacterium ulcerans vaccine(Swiss Tropical and Public Health Institute)

Mycobacterium

Mosquito autodissemination stations cut Buruli ulcer risk by 83% in Melbourne trial

Machine Learning and Chemical Features Unlock Mycomembrane Permeation in Mycobacterium tuberculosis

AN2 Therapeutics Receives FDA Clearance for Epetraborole Trial in Mycobacterium abscessus Lung Disease